Skip to main content
Advertisement
Home

Main navigation

  • Digital Issue Archive
  • Service Directory
  • Awards
  • Advertise
  • Subscribe now

Secondary

  • Travel Insurance
  • Policies & Partnerships
  • Travel Risk Management
  • Travel Trends
  • Hospitals & Healthcare
  • Industry Moves
  • Reviews
International Hospitals & Healthcare Part of the IH&H family
Part of the
IH&H family
International Hospitals & Healthcare

DRC Ebola outbreak reaches 3,360 cases

Travel Risk Management
31 Jul 2026 | Oliver Cuenca
Share
Medical testing ebola

The viral outbreak is the fastest-growing ever managed by the World Health Organization (WHO), with around 44% of reported cases proving fatal

The ongoing Bundibugyo Ebola outbreak in the Democratic Republic of Congo (DRC) has reached 3,360 cases across five provinces as of 27 July, with 1,487 recorded deaths – an overall death rate of around 44%.

The figures represent a major increase compared with those released on 11 July, when there were just under 2,000 confirmed cases, and around 700 deaths. At that time, the WHO had already declared the Ebola outbreak the fastest-growing it had ever managed.

The medical response to the viral outbreak has been hindered, in part by local distrust and violence against healthcare officials, and by resource shortages.

Dr Chikwe Ihekweazu, Executive Director of the WHO’s Health Emergencies Programme, described the outbreak as a “fire” at a press conference in Geneva earlier this month, warning that “80% of new cases outside of our contact lists, and so are coming to us from unknown chains of transmission.”

The WHO also stated that many of the newly reported deaths are people who died without ever reaching a health facility or receiving care – a fact which Dr Ihekweazu described as the “most alarming finding.”

A two-pronged approach

The WHO has outlined a two-part strategy for its response to the virus – continuing to focus heavily on cases in Ituri, where the vast majority of cases originate, but also working to understand the travel routes, and map out where there are risks of new cases emerging.

Several therapeutic drugs are currently undergoing clinical trials, but there is currently no approved treatment for patients with the Bundibugyo species of Ebola. Despite this, the WHO stated that chances of survival increase significantly with early, supportive care.

“We must find the cases earlier, bring them into care as soon as possible” to reduce transmission in the community and avoid staying behind the curve,” explained Dr Ihekweazu.

Travel Risk Management
31 Jul 2026
Share

Oliver Cuenca

Oliver Cuenca is a Junior Editor for Voyageur Group, joining in 2021. He writes for both ITIJ and AirMed&Rescue, covering a range of topics including international travel and health insurance, medical assistance provision and air medical transportation. He also serves as Title Editor of the Assistance & Repatriation Reviews. Oliver holds an MA in Magazine Journalism from Cardiff University, as well as a BA in English with Creative Writing from Falmouth University.

Keep on reading

No results

There are no results available matching your search term.

Why subscribe to ITIJ?

In-depth analysis

In-depth analysis

Unique insights and expert opinions on the latest industry developments

A wider perspective

A wider perspective

Get the global view on the topics that are trending in your region

Breaking news

Breaking news

ITIJ.com has all the latest news relevant to travel insurance and IPMI professionals

Subscribe now
ITIJ IH&H

Footer menu

  • About Us
  • Subscribe
  • Advertise
  • Contact
  • Privacy Policy
  • Terms
  • Voyageur
International Travel & Health Insurance Conferences

Social

  • LinkedIn link
  • Twitter link

© Voyageur Publishing & Events 2026

Close